News

A doctor has warned of the potential dangers of a 'game changing' diabetes drug which could rival the likes of Ozempic. The medication - and similar drugs - have been catapulted into the heart of pop ...
Runners, cyclists and other fitness enthusiasts say weight-loss drugs give them a performance edge, despite potential risks.
Now, alarmed by sunken features and sagging skin, newly svelte patients are flooding med spas and plastic surgery clinics, desperate to plump, lift and smooth their way back to a youthful glow. These ...
Taking the drug made one writer feel so sick she quit and focused on healthy habits instead of her body size. Turns out, 65% ...
Novo Nordisk's booming obesity drugs & diabetes portfolio make it a top growth play. Click here to read an analysis of NVO ...
WWE Monday Night RAW Results: As WrestleMania edges closer, tensions are bound to rise in the middle of the squared ring. The final Raw and Smackdown episodes just before the big day ... who delivered ...
(Photo: Pixabay) According to stock market experts, in Q4 results 2025 ... earnings and avoid taking any position in realty stocks before that." Highlighting the impact of the slowdown on Dalal ...
Parker Waichman LLP is currently accepting cases nationwide for individuals who have suffered vision loss, blindness, or serious optic nerve damage after taking Ozempic or Wegovy. Victims may ...
Costco's March sales results reaffirm its position as a dependable stock in the retail sector, backed by strong membership growth, consistent comparable sales improvement and solid financial ...
With the impressive results ... after losing 2st (13kg) with the GLP-1 jab liraglutide, participants who slept badly were more likely to regain weight. Here are six key questions to consider ...
Serial Salesman: Kailera CEO Ron Renaud has built and sold three biotechs, the last for $8.7 billion. “Companies get bought, they don’t get sold,” he says. But the obesity market’s frenzy ...